Global Blood Therapeutics (NASDAQ:GBT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Global Blood Therapeutics beat estimated earnings by 3.08%, reporting an EPS of $-1.26 versus an estimate of $-1.3.
Revenue was up $16.12 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.23 which was followed by a 4.93% increase in the share price the next day.
Here's a look at Global Blood Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.13 | -1.11 | -1.19 | -1.01 |
| EPS Actual | -1.36 | -1.13 | -1.12 | -1.21 |
| Revenue Estimate | 55.44M | 53.70M | 43.84M | 43.00M |
| Revenue Actual | 56.10M | 52.05M | 47.55M | 39.04M |
To track all earnings releases for Global Blood Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
